Mixed-valence μ3-oxo-centered triruthenium cluster [Ru3(II,III,III)(μ3-O)(μ-CH3CO2)6(H2O)3]·2H2O: Synthesis, structural characterization, valence-state delocalization and catalytic behavior

Add time:07/31/2019    Source:sciencedirect.com

The oxo-centered, trinuclear, mixed valence [Ru3(II,III,III)O(CH3CO2)6(H2O)3]·2H2O (2) acetate complex has been prepared with high yield through reduction of [Ru3(III,III,III)O(CH3CO2)6(CH3OH)3]·CH3CO2 precursor compound in presence of muccic acid under hydrothermal conditions. The crystalline trinuclear oxo-cluster has been obtained as crystalline powder and characterized by single-crystal and powder X-ray diffraction, elemental analysis, SEM, TGA, IR spectroscopy. Complex 2 composes of μ3-oxocentered trinuclear ruthenium array and exhibits the oxidation state delocalization between three Ru atoms at 293 K. Accurate single-crystal analysis along with valence bond calculations reveal trapped-valence state delocalization at room temperature, whereas three-site relaxation occurs at 100 K leading to Ru(II) and Ru2(III) formal states. Moreover, the mixed valence of RuIIRu2III unit in compound 2 has been confirmed by XANES spectroscopy. The catalytic behavior of oxo-centered triruthenium complex 2 has been examined in hydration of nitriles and isomerization of allylic alcohols reactions both realized in aqueous media.

We also recommend Trading Suppliers and Manufacturers of 4-METHYL-5-OXO-HEXANENITRILE (cas 10413-01-1). Pls Click Website Link as below: cas 10413-01-1 suppliers

Prev:Determination of nucleic acids based on shifting the association equilibrium between tetracarboxy aluminum phthalocyanine and poly-lysine
Next:2-Phenyl-1-[4-(2-piperidine-1-yl-ethoxy)benzyl]-1H-benzimidazoles as ligands for the estrogen receptor: Synthesis and pharmacological evaluation)